[Medical angiotensin II-receptor blockade in hypertension and heart failure].
van Zwieten
P A
PA
Afd. Farmacotherapie, Academisch Medisch Centrum, Amsterdam.
Lie
K I
KI
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use; D019808:Losartan; D013777:Tetrazoles / Q000627:therapeutic use; D000092502:Renin Inhibitors
D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D002317:Cardiovascular Agents; D007093:Imidazoles; D019808:Losartan; D013777:Tetrazoles; D000092502:Renin Inhibitors
Medicamenteuze angiotensine II-receptorblokkade bij hypertensie en hartfalen.